Entresto® is a leading prescription medication developed by Novartis Pharmaceuticals for adults battling chronic heart failure. Designed to improve heart function, Entresto® combines two active ingredients, sacubitril and valsartan, working together to help reduce the risk of hospitalization and death related to heart failure. The brand emphasizes patient education, providing valuable resources for understanding heart failure symptoms, management strategies, and the importance of proactive health care conversations.

Entresto® aims to empower patients with knowledge about their condition and support their journey toward better heart health. The brand also offers treatment support services, including ways to save on medications and access lifestyle guidance tailored for those diagnosed with heart failure. With a commitment to improving the quality of life for individuals affected by heart failure, Entresto® stands at the forefront of innovative heart health treatments, enhancing patient care through both effective medication and comprehensive support